INFLIXIMAB MODULATES MUCOSAL CYTOKINE PROFILE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

被引：0
|
作者：
Caprioli, F. [1 ]
Bose, F. [2 ]
Raeli, L. [2 ]
Vigano, C. [3 ]
Basilisco, G. [1 ]
Conte, D. [3 ]
Abrignani, S. [2 ]
Reali, E. [2 ]
机构：
[1] Fdn IRCCS Osped Maggiore Policlin Mangiagalli & R, Gastroenterol Unit 2, Milan, Italy
[2] INGM, Milan, Italy
[3] Univ Milan, Dept Med Sci, Milan, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2010年 / 42卷
关键词：
D O I：
10.1016/S1590-8658(10)60175-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P.62
引用
收藏
页码：S125 / S125
页数：1
相关论文
共 50 条
  • [41] Association Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Inflammatory Bowel Diseases
    Roblin, Xavier
    Marotte, Hubert
    Rinaudo, Melanie
    Del Tedesco, Emilie
    Moreau, Amelie
    Phelip, Jean Marc
    Genin, Christian
    Peyrin-Biroulet, Laurent
    Paul, Stephane
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (01) : 80 - +
  • [42] THE ROLE OF SUB-MUCOSAL COLLAGEN DEPOSITION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
    Triantos, Christos
    Tsolias, Chrisostomos
    Forlano, Roberta
    Karaivazoglou, Katerina
    Manolakopoulos, Spilios
    Aggeletopoulou, Ioanna
    Theocharis, Georgios
    Melachrinou, Maria
    Goldin, Robert
    Thomopoulos, Konstantinos
    Manousou, Pinelopi
    GASTROENTEROLOGY, 2019, 156 (06) : S447 - S447
  • [43] Mucosal healing in a cohort of inflammatory bowel diseases paediatric patients in clinical remission
    Giugliano, F. P.
    Strisciuglio, C.
    Martinelli, M.
    Andreozzi, M.
    Cenni, S.
    Staiano, A.
    Miele, E.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S256 - S256
  • [44] Intermittent Appearance of Antibodies to Infliximab Is Not Associated With Reduced Efficacy in Patients With Inflammatory Bowel Diseases
    Awadie, Halim
    Waterman, Matti
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2022, 56 (01) : E47 - E51
  • [45] Accurate and rapid microfluidic ELISA to monitor Infliximab titers in patients with inflammatory bowel diseases
    Iria, Ines
    Soares, Ruben R. G.
    Bras, Eduardo J. S.
    Chu, Virginia
    Goncalves, Joao
    Conde, Joao P.
    ANALYST, 2022, 147 (03) : 480 - 488
  • [46] Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases
    Cocco, Andrea
    Angelucci, Erika
    Viscido, Angelo
    Caprilli, Renzo
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (10) : 1317 - 1319
  • [47] ENHANCED MUCOSAL CYTOKINE PRODUCTION IN INFLAMMATORY BOWEL-DISEASE
    PULLMAN, WE
    ELSBURY, S
    KOBAYASHI, M
    HAPEL, AJ
    DOE, WF
    GASTROENTEROLOGY, 1992, 102 (02) : 529 - 537
  • [48] Analysis of cytokine messenger RNA profile in patients with inflammatory bowel disease.
    Sawa, Y
    Matsumoto, T
    Jinno, Y
    Hara, J
    Nakamura, S
    Oshitani, N
    Adachi, K
    Kitano, A
    Nishiguchi, Y
    Hirakawa, K
    Arakawa, T
    GASTROENTEROLOGY, 2000, 118 (04) : A1368 - A1368
  • [49] The association of the quality of sleep with proinflammatory cytokine profile in inflammatory bowel disease patients
    Sobolewska-Wlodarczyk, Aleksandra
    Wlodarczyk, Marcin
    Talar, Marcin
    Wisniewska-Jarosinska, Maria
    Gasiorowska, Anita
    Fichna, Jakub
    PHARMACOLOGICAL REPORTS, 2021, 73 (06) : 1660 - 1669
  • [50] The association of the quality of sleep with proinflammatory cytokine profile in inflammatory bowel disease patients
    Aleksandra Sobolewska-Włodarczyk
    Marcin Włodarczyk
    Marcin Talar
    Maria Wiśniewska-Jarosińska
    Anita Gąsiorowska
    Jakub Fichna
    Pharmacological Reports, 2021, 73 : 1660 - 1669
12345